Back
Goldman Sachs Access Treasury 0-1 Year ETF Vs. Surgery Partners, Inc. Industry Stock Comparison
Sell
36
GBIL
Goldman Sachs Access Treasury 0-1 Year ETF
Last Price:
$100.26
Seasonality Move:
0.01%
Sell
36
SGRY
Surgery Partners, Inc.
Last Price:
$15.66
Seasonality Move:
7.34%
Sell
36
Goldman Sachs Access Treasury 0-1 Year ETF (GBIL)
is a Sell
Is Goldman Sachs Access Treasury 0-1 Year ETF a Buy, Sell or Hold?
-
The current Goldman Sachs Access Treasury 0-1 Year ETF [GBIL] share price is $100.24. The Score for GBIL is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
GBIL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Surgery Partners, Inc. (SGRY)
is a Sell
Is Surgery Partners, Inc. a Buy, Sell or Hold?
-
The current Surgery Partners, Inc. [SGRY] share price is $15.75. The Score for SGRY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
SGRY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GBIL Stock Price Chart
What is Goldman Sachs Access Treasury 0-1 Year ETF's stock price today?
-
The Goldman Sachs Access Treasury 0-1 Year ETF share price today is $100.24Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GBIL is experiencing selling pressure, which indicates risk of future bearish movement.
SGRY Stock Price Chart
What is Surgery Partners, Inc.'s stock price today?
-
The Surgery Partners, Inc. share price today is $15.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SGRY is experiencing slight selling pressure.
GBIL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 70.96 | Buy |
| Chaikin Money Flow: | -590810 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (100.01 - 100.19) | Buy |
| Bollinger Bands (100): | (99.96 - 100.16) | Buy |
SGRY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.36 | Buy |
| Relative Strength Index (14 RSI): | 40.06 | Sell |
| Chaikin Money Flow: | -546532 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.64 - 16.98) | Sell |
| Bollinger Bands (100): | (17.06 - 22.88) | Sell |
GBIL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100.18 | Buy |
| 20-day SMA: | 100.09 | Buy |
| 50-day SMA: | 100.08 | Buy |
| 200-day SMA: | 100.04 | Buy |
| 8-day EMA: | 100.18 | Buy |
| 20-day EMA: | 100.12 | Buy |
| 50-day EMA: | 98.59 | Buy |
| 200-day EMA: | 65.05 | Buy |
SGRY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.73 | Buy |
| 20-day SMA: | 16.23 | Sell |
| 50-day SMA: | 17.95 | Sell |
| 200-day SMA: | 21.2 | Sell |
| 8-day EMA: | 13.62 | Buy |
| 20-day EMA: | 8.66 | Buy |
| 50-day EMA: | 4.31 | Buy |
| 200-day EMA: | 1.21 | Buy |
Goldman Sachs Access Treasury 0-1 Year ETF Earnings Growth & GBIL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Surgery Partners, Inc. Earnings Growth & SGRY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and a decrease next year of $0.00 per share.
Goldman Sachs Access Treasury 0-1 Year ETF Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Surgery Partners, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||